Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents-Reference-Cited by-同舟云学术

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

Published:2011-05-30 Issue:3 Volume:130 Page:735-742
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Terpos Evangelos,Anargyrou Konstantinos,Katodritou Eirini,Kastritis Efstathios,Papatheodorou Athanasios,Christoulas Dimitrios,Pouli Anastasia,Michalis Eurydiki,Delimpasi Sosana,Gkotzamanidou Maria,Nikitas Nikitas,Koumoustiotis Vasilios,Margaritis Dimitrios,Tsionos Konstantinos,Stefanoudaki Ekaterini,Meletis John,Zervas Konstantinos,Dimopoulos Meletios A.,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Prognostic value of bone marrow angiogenesis in multiple myeloma;Rajkumar;Clin Cancer Res,2000

2. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis;Rajkumar;Clin Cancer Res,2002

3. Novel anti-myeloma agents and angiogenesis;Anargyrou;Leuk Lymphoma,2008

4. Clinician guide to angiogenesis;Fam;Circulation,2003

5. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis;Giuliani;Blood,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression;Cancers;2023-09-12

2. Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma;Frontiers in Oncology;2023-06-08

3. Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression;World Journal of Stem Cells;2023-05-26

4. Evaluation of angiopoietin-2 level in patients with multiple myeloma at presentation and in remission state;Iraqi Journal of Hematology;2023

5. Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance;Journal of Clinical Medicine;2022-11-01